Sarcopenia: Molecular Pathways and Potential Targets for Intervention
- PMID: 33266508
- PMCID: PMC7700275
- DOI: 10.3390/ijms21228844
Sarcopenia: Molecular Pathways and Potential Targets for Intervention
Abstract
Aging is associated with sarcopenia. The loss of strength results in decreased muscle mass and motor function. This process accelerates the progressive muscle deterioration observed in older adults, favoring the presence of debilitating pathologies. In addition, sarcopenia leads to a decrease in quality of life, significantly affecting self-sufficiency. Altogether, these results in an increase in economic resources from the National Health Systems devoted to mitigating this problem in the elderly, particularly in developed countries. Different etiological determinants are involved in the progression of the disease, including: neurological factors, endocrine alterations, as well as nutritional and lifestyle changes related to the adoption of more sedentary habits. Molecular and cellular mechanisms have not been clearly characterized, resulting in the absence of an effective treatment for sarcopenia. Nevertheless, physical activity seems to be the sole strategy to delay sarcopenia and its symptoms. The present review intends to bring together the data explaining how physical activity modulates at a molecular and cellular level all factors that predispose or favor the progression of this deteriorating pathology.
Keywords: aging; inflammation; oxidative stress; physical activity; sarcopenia; satellite cells.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures

Similar articles
-
Regenerative decline of stem cells in sarcopenia.Mol Aspects Med. 2016 Aug;50:109-17. doi: 10.1016/j.mam.2016.02.002. Epub 2016 Feb 24. Mol Aspects Med. 2016. PMID: 26921790 Review.
-
Molecular mechanisms in aging and current strategies to counteract sarcopenia.Curr Aging Sci. 2010 Jul;3(2):90-101. doi: 10.2174/1874609811003020090. Curr Aging Sci. 2010. PMID: 20158492 Review.
-
The physiopathologic role of oxidative stress in skeletal muscle.Mech Ageing Dev. 2018 Mar;170:37-44. doi: 10.1016/j.mad.2017.08.009. Epub 2017 Aug 26. Mech Ageing Dev. 2018. PMID: 28851603 Review.
-
Sarcopenia in older mice is characterized by a decreased anabolic response to a protein meal.Arch Gerontol Geriatr. 2017 Mar-Apr;69:134-143. doi: 10.1016/j.archger.2016.11.014. Epub 2016 Nov 27. Arch Gerontol Geriatr. 2017. PMID: 27918964
-
Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.Mol Aspects Med. 2016 Aug;50:1-32. doi: 10.1016/j.mam.2016.06.001. Epub 2016 Jun 28. Mol Aspects Med. 2016. PMID: 27370407 Review.
Cited by
-
A posteriori dietary patterns in 71-year-old Swedish men and the prevalence of sarcopenia 16 years later.Br J Nutr. 2021 Sep 29;128(5):1-12. doi: 10.1017/S0007114521003901. Online ahead of print. Br J Nutr. 2021. PMID: 34585650 Free PMC article.
-
Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS.J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):1915-1929. doi: 10.1002/jcsm.13541. Epub 2024 Jul 12. J Cachexia Sarcopenia Muscle. 2024. PMID: 39001569 Free PMC article.
-
Sarcopenia in Menopausal Women: Current Perspectives.Int J Womens Health. 2022 Jun 23;14:805-819. doi: 10.2147/IJWH.S340537. eCollection 2022. Int J Womens Health. 2022. PMID: 35769543 Free PMC article. Review.
-
Adverse childhood experiences, sarcopenia, and social participation in older adults: a cohort study.BMC Public Health. 2024 Mar 5;24(1):711. doi: 10.1186/s12889-024-18138-0. BMC Public Health. 2024. PMID: 38443827 Free PMC article.
-
Potential Benefits of Epidermal Growth Factor for Inhibiting Muscle Degrative Markers in Rats with Alcoholic Liver Damage.Int J Mol Sci. 2023 May 16;24(10):8845. doi: 10.3390/ijms24108845. Int J Mol Sci. 2023. PMID: 37240190 Free PMC article.
References
-
- Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.-P., Rolland Y., Schneider S.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources